These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28230853)

  • 1. Mesenchymal stromal cells inhibit CD25 expression via the mTOR pathway to potentiate T-cell suppression.
    Yoo HS; Lee K; Na K; Zhang YX; Lim HJ; Yi T; Song SU; Jeon MS
    Cell Death Dis; 2017 Feb; 8(2):e2632. PubMed ID: 28230853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase.
    Kimball SR; Siegfried BA; Jefferson LS
    J Biol Chem; 2004 Dec; 279(52):54103-9. PubMed ID: 15494402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Han S; Khuri FR; Roman J
    Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-induced stimulation of protein synthesis and survival in IPEC-J2 cells is mediated by mTOR but not nitric oxide.
    Bauchart-Thevret C; Cui L; Wu G; Burrin DG
    Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E899-909. PubMed ID: 20841502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation dynamics of eukaryotic initiation factor 4E binding protein 1 (4E-BP1) is discordant with its potential to interact with eukaryotic initiation factor 4E (eIF4E).
    Showkat M; Beigh MA; Bhat BB; Batool A; Andrabi KI
    Cell Signal; 2014 Oct; 26(10):2117-21. PubMed ID: 24975846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S6K1 regulates hematopoietic stem cell self-renewal and leukemia maintenance.
    Ghosh J; Kobayashi M; Ramdas B; Chatterjee A; Ma P; Mali RS; Carlesso N; Liu Y; Plas DR; Chan RJ; Kapur R
    J Clin Invest; 2016 Jul; 126(7):2621-5. PubMed ID: 27294524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation.
    Shuda M; Velásquez C; Cheng E; Cordek DG; Kwun HJ; Chang Y; Moore PS
    Proc Natl Acad Sci U S A; 2015 May; 112(19):5875-82. PubMed ID: 25883264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway.
    Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J
    Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restorative Mechanisms Regulating Protein Balance in Skeletal Muscle During Recovery From Sepsis.
    Crowell KT; Soybel DI; Lang CH
    Shock; 2017 Apr; 47(4):463-473. PubMed ID: 27749759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells.
    Bishop JD; Nien WL; Dauphinee SM; Too CK
    J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLD1 regulates mTOR signaling and mediates Cdc42 activation of S6K1.
    Fang Y; Park IH; Wu AL; Du G; Huang P; Frohman MA; Walker SJ; Brown HA; Chen J
    Curr Biol; 2003 Dec; 13(23):2037-44. PubMed ID: 14653992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
    Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
    J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
    Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
    [No Abstract]   [Full Text] [Related]  

  • 17. The GST-BHMT assay reveals a distinct mechanism underlying proteasome inhibition-induced macroautophagy in mammalian cells.
    Rui YN; Xu Z; Chen Z; Zhang S
    Autophagy; 2015; 11(5):812-32. PubMed ID: 25984893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Glutamine enhances enterocyte growth via activation of the mTOR signaling pathway independently of AMPK.
    Yi D; Hou Y; Wang L; Ouyang W; Long M; Zhao D; Ding B; Liu Y; Wu G
    Amino Acids; 2015 Jan; 47(1):65-78. PubMed ID: 25280462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
    Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
    Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.